Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$15,459,251
+$2,373,313 QoQ
Shares Held
61,434
+2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#727
of 4,153 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coastal Bridge Advisors, LLC holds $56,459,277 across 9 Drug Manufacturers - General names. ABBV ranks #2 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
62,933 | $15,983,094 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
61,434 | $15,459,251 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
68,834 | $8,696,487 | |
| 4 | AMGN |
Amgen Inc
|
14,287 | $5,173,608 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
56,768 | $3,270,972 | |
| 6 | LLY |
ELI LILLY & Co
|
2,467 | $2,958,994 | |
| 7 | MRK |
Merck & Co., Inc.
|
21,141 | $2,716,618 | |
| 8 | PFE |
Pfizer Inc
|
78,442 | $1,888,883 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,459,251 | 61,434 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $13,085,938 | 60,168 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,633,541 | 59,668 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $14,088,051 | 60,845 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $11,306,114 | 60,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,543,962 | 59,870 | Shares | Sole | 2025-08-25 | |
| 2024-09-30 | $207,946 | 1,053 | Shares | Sole | 2024-11-14 | |
| 2022-12-31 | $218,658 | 1,353 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||